OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Endocrinology Diabetes and Obesity is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Utilizing type 2 diabetes medications outside glycemic parameters – where are we headed?	51
Obesity and infertility: a double whammy	40
Updates in thyroid healthcare delivery: advancing patient-centered care	37
Editorial: Health considerations across the lifespan for patients with polycystic ovary syndrome	31
Advances in assessment and treatment of bone, mineral and parathyroid disorders	30
Nutrition and thyroid disease	24
MR-based techniques for intracortical vessel visualization and characterization: understanding the impact of microvascular disease on skeletal health	24
Editorial introduction	22
Editorial introduction	22
Financial toxicity in thyroid cancer survivors	21
Beyond weight loss: tirzepatide as a dual GIP/GLP-1 receptor agonist for obstructive sleep apnea	21
Detection strategies for elevated lipoprotein(a): will implementation let the genie out of the bottle?	20
Prevalence and correlates of androgen dependence: a meta-analysis, meta-regression analysis and qualitative synthesis	20
Editorial introduction	18
Recent advances in anaplastic thyroid cancer management	18
Preventing type 1 diabetes development and preserving beta-cell function	18
Interactions between antidiabetes medications and heart–brain axis	17
Update on fracture risk assessment in osteoporosis	15
An update on bone in diabetes	15
Low-carbohydrate diets in type 1 diabetes: balancing benefits and risks	14
Bone marrow fibrocytes: villain or white knight in thyroid-associated ophthalmopathy?	14
Fibrous dysplasia in children and its management	14
The use of anabolic agents in the treatment of osteoporosis: a clinical update	14
Targeting apolipoprotein C-III: a game changer for pancreatitis prevention in severe hypertriglyceridemia	14
The role for long-term use of dehydroepiandrosterone in adrenal insufficiency	14

Assisted reproductive technology outcomes and management considerations for people with epilepsy	13
Glucocorticoid withdrawal syndrome: what to expect and how to manage	13
Epidemiologic changes in thyroid disease	13
Precision medicine in diabetes care	13
Hypertriglyceridemia: updates from clinical trials of new agents and real-world registries	12
Editorial introductions	12
The uncommon forms of congenital adrenal hyperplasia	12
Editorial introductions	12
Type 2 diabetes: a contemporary view from the Asian lens	12
New perspectives on the high-density lipoprotein system and its role in the prevention and treatment of atherosclerotic cardiovascular disease	11
Recent advances in fibroblast growth factor 23-related hypophosphatemic disorders	11
Adrenal insufficiency and pregnancy	10
Induction of antigenic immune tolerance to delay type 1 diabetes – challenges for clinical translation	10
TSHR-IGF-IR complex drives orbital fibroblast misbehavior in thyroid eye disease	10
An update on investigation and management of renal bone disease	10
A short history of saturated fat: the making and unmaking of a scientific consensus	10
Editorial introductions	10
Short-term hyper-caloric high-fat feeding on a ketogenic diet can lower low-density lipoprotein cholesterol: the cholesterol drop experiment	9
Editorial introductions	9
Legislation, medicine, and politics: care for gender diverse youth	9
Time to cycle regularity and health risks	9
Novel techniques for assessment of bone tissue material properties	9
Editorial introductions	9
Indications for testosterone therapy in men	8
Type 2 diabetes mellitus and cognitive function: understanding the connections	8
Multifactorial chylomicronemia syndrome	8
Self-antigens, benign autoimmunity and type 1 diabetes: a beta-cell and T-cell perspective	8
The future of triglyceride-regulating therapies and registries	8
The interaction between gut microbiome and bone health	8
Advanced imaging and theranostics in thyroid cancer	7
Microbiome-derived signaling molecules and the brain–gut axis: emerging mechanisms and clinical implications	7
Assessing the contribution of plastic-associated obesogenic compounds to cardiometabolic diseases	7
Treating obesity in type 1 diabetes mellitus – review of efficacy and safety	7
The 1 mg overnight dexamethasone suppression test: a danger to the adrenal gland?	7
Testosterone and the prevention of type 2 diabetes mellitus: therapeutic implications from recent trials	6
When history, law, and medicine intersect	6
The psychosocial impact of thyroid cancer	6
Editorial introductions	6
Radiofrequency ablation (RFA) compared to observation for benign thyroid nodules: emerging considerations for judicious use	6
Bridging the LatinX community care gap	6
Predictors of cardiovascular risk in familial hypercholesterolemia	6
Gestational diabetes and other adverse pregnancy outcomes in polycystic ovary syndrome	6
Current challenges in Cushing's syndrome testing: blood, saliva, urine, or hair?	5
Fracture prediction tools in diabetes	5
Preconception health optimization in women with polycystic ovary syndrome − how to find the time?	5
Editorial: New horizons for thyroid diseases: transformative changes and tailored care	5
Can artificial intelligence and wearable technologies transform diabetes foot health?	5
Recent advances in the role of miRNAs in bone disease	5
Skeletal health in diabetes	5
Mixed-methods research on androgen abuse – a review	5

Update on management of paediatric dyslipidaemia	4
Overview of diabetes agents in cardiovascular disease: it takes an orchestra to play Tchaikovsky in symphony	4
Bone marrow adiposity in diabetes and clinical interventions	4
Potassium-competitive acid blockers and acid-related disorders	4
Editorial introductions	4
Better care for women with polycystic ovary syndrome – a proposal for an international evidence based best practice framework to improve care	4
The psychological dimension of obesity – an uncharted territory	4
Metabolic dysfunction and the use of adjunct medications in type 1 diabetes	4
Editorial: Childhood endocrine and genetic disorders: improving adult outcomes	4
Biomarkers in gastroenteropancreatic neuroendocrine neoplasms	4
Prediabetes and skeletal health	4
Glutamic acid decarboxylase immunotherapy for type 1 diabetes	4
Coronary artery event-free or resilient familial hypercholesterolemia: what's in a name?	3
Hypoparathyroidism update	3
An update: maternal iodine supplementation, thyroid function tests, and child neurodevelopmental outcomes	3
Health effects of androgen abuse: a review of the HAARLEM study	3
Parathyroid hormone assays in 2026: second versus third generation, standardization, and clinical interpretation	3
The approaches and challenges in the management of differentiated thyroid carcinoma	3
Cardiometabolic risk and therapeutic outcomes in mild autonomous cortisol secretion	3
Use of anti-Müllerian hormone for understanding ovulatory dysfunction in polycystic ovarian syndrome	3
Differences in the management of thyroid nodules in children and adolescents as compared to adults	3
Emerging treatment for congenital adrenal hyperplasia	3
Mouse models of type 1 diabetes and their use in skeletal research	3
Subclinical hyperthyroidism	3
Cardiovascular disease in metabolic-associated fatty liver disease	3
The evolution of C-peptide's role in diabetes care	3
Adjunctive diabetes therapies and cardiovascular protection in type 1 diabetes: tackling the challenging Tchaikovsky piece	3
Glucagon-like peptide-1 receptor agonists and safety in the preconception period	3
Obesity during pregnancy: contemporary evidence and clinical implications	3
Selective progesterone receptor modulators and reproductive health	2
Emerging concepts in the diagnosis and management of metabolically associated steatotic liver disease	2
Obesity-related glomerulopathy: a lesser known complication of obesity	2
Adherence to pharmacotherapy: sine qua non for reducing cumulative risk of premature coronary disease in familial hypercholesterolemia	2
Editorial introductions	2
Editorial overview	2
Current perspectives on biomarkers in metabolic bone disease	2
Editorial introduction	2
Under and overtreatment with thyroid hormone replacement during pregnancy	2
Can remnant cholesterol (triglyceride-rich lipoproteins) reclassify estimated risk of atherosclerotic cardiovascular disease?	2
Editorial introduction	2
Use of calculated free testosterone in men: advantages and limitations	2
Effect of incretins on skeletal health	2
Editorial introductions	2
Eicosapentaenoic acid vs. docosahexaenoic acid for the prevention of cardiovascular disease	2
Addressing genetic and environmental sources of cardiometabolic disease	2